Modalis TMS’ Post

Austedo (deutetrabenazine) is a prescription medication primarily used for the management of chorea associated with Huntington's disease, a hereditary neurological disorder. Additionally, it is prescribed for the treatment of tardive dyskinesia, a condition characterized by repetitive and involuntary movements often stemming from prolonged use of certain psychiatric medications. Austedo works by modulating dopamine levels in the brain, specifically targeting areas involved in movement regulation. It's important to follow healthcare provider guidance closely when using Austedo and to discuss potential benefits and risks. - Want to learn more? Contact Us: Phone Number: (561) 846 -0367 Website: https://lnkd.in/eyC82N2P Email: support@mywellnesspsychiatry.com *In-person or Telehealth options available #depression #depressionhelp #anxiety #anxietyhelp #mentalhealth #mentalhealthawareness #ocd #ptsd #bipolar #substanceabuse #mindspa #floridamentalhealth #floridapsychiatry #psychiatricnursepractitioner #miami #southbeach #florida #southflorida #floridacounseling #uf #fau #fsu #bocaraton

TMS explained 🧠 Transcranial Magnetic Stimulation (TMS) is a form of brain stimulation that uses electromagnetism to stimulate the nerve cells in the brain. By repetitively exciting or inhibiting these cells using the stimulation, TMS can produce long lasting changes in the brain to help treat a range of conditions. TMS is also typically used when other treatments have not worked. It is currently TGA-approved in Australia for the treatment of depression, with Medicare rebates now available for eligible* adult patients that have tried two or more antidepressant medications without any significant benefits to their symptoms. TMS may also help patients with other conditions, such as OCD, PTSD, pain management and tinnitus, with evidence continuing to emerge for a range of psychiatric and neurological conditions. 👉 For more information on TMS and how it works, visit our website at www.modalis.com.au or email our friendly team at tms@modalis.com.au. #tms #transcranialmagneticstimulation #repetitivetranscranialmagneticstimulation #rtms #brainstimulation #tmsaustralia #perthmedicalcommunity #TMSperth #depression #midland

PANS/PANDAS exists - it’s not up for debate. 👉 The conditions are characterized by a sudden onset of OCD and/or tics, accompanied by other psychiatric symptoms such as anxiety, mood swings, and aggression. They’re believed to be triggered by infections, leading to an autoimmune response that affects the brain. We need to keep learning more about them and spreading awareness because swift diagnosis can lead to more effective interventions. And when it comes to neurological disorders, waiting around is not recommended. Your brain is incredibly important! 🙏 At TicTock Therapy, we're committed to boosting awareness and providing tailored treatments that offer hope and healing to children and their families. For more resources, visit the Children's e-Hospital. Get in touch. #MentalHealth #Therapy #PANDAS

NeuroStar TMS Therapy Offers Hope for patients with depression in Redding. Research reveals a striking statistic: with each new medication attempted, the likelihood of experiencing relief diminishes. TMS therapy, a non-drug treatment for depression, offers patients hope. Psychiatric Care Center in Redding is a NeuroStar TMS provider. Learn more about TMS at PCC. https://lnkd.in/gVDWWEfV #TMS #NeuroStarTMS #tmstherapy

Did you know that diagnoses can and do change over time? A diagnosis describes the state of your brain's neural connections and emotional responses at any given moment. Your diagnosis is a list of symptoms we track, measuring improvement (or lack thereof) in relation to our interventions. A diagnosis is not a genetic code that charts the destiny of how you think, feel, and act.  When you include integrative psychiatric care in your treatment plan, you are taking an approach to your recovery that guides you through any shifts in diagnosis. We look at all of the symptoms individually and as a whole, addressing them in the way that fits your needs most, with or without medication.  If you have been wondering what a different approach to your wellness plan could feel like, I would love to connect with you about integrative psychiatric care and if that may be a fit for you. Visit the comments or my bio to book your first appointment today and start investing in your health with support along the way.   #PsychiatricNursePractitioner #IntegrativeHealth #IntegrativeMedicine #AcceptingNewPatients

The powerful duo of psychiatric medications and therapy addresses both symptoms and underlying issues, leading to a more comprehensive recovery. #powerfulduo #psychiatricmedication #therapy #address #leading #duo #medications #symptom #issues #recovery

Women were twice as likely to develop Bipolar Disorder for the first time during perimenopause , compared to before perimenopause. A team at Cardiff University School of Medicine and Bipolar UK studied 128,294 females from the UK. They looked at perimenopause to see if it was associated with an increased risk of developing psychiatric disorders for the first time. The results showed that perimenopausal women are more likely to experience bipolar disorder and major depressive disorders. Please book an appointment if you aren’t sure if you’re perimenopausal, are concerned about the safety and efficacy of HRT, or are just curious to learn more. @menopausefact.notfiction #menopausefact.notfiction #menopause #menopauseeducation #memopausesupport #midlifemadness #bipoaruk #bipolar

Childhood trauma, with subsequent trauma reactions and risky behaviours, is associated with pain. This means that already-vulnerable adolescents and young adults might be at risk of receiving prescriptions for opioid and nonopioid analgesics when they seek paincare. A Norwegian study* investigated the relationship of a range of childhood trauma exposures to risk of receiving prescriptions for opioid and nonopioid analgesics and, particularly, whether exposure to multiple trauma types would predict a very high prescription rate. They found that: ·        Overall, exposure to childhood trauma was consistently and significantly related to higher prescription rates for opioids throughout adolescence and young adulthood. ·        A higher cumulative load of trauma was linked to higher prescription rates for both opioid and nonopioid analgesics - suggesting there may be a dose-response relationship. This study highlights the need for prescribers to exercise extreme caution in prescribing opioids for this population. Furthermore, all practitioners need to use a trauma-informed and tailored approach to pain management for each vulnerable young person seeking help. Are you a mental health professional interested in learning more about the link between childhood trauma and pain? Find out about learning opportunities at trainpainacademy.co.za *Reference: https://lnkd.in/dEswuqQj Baumann-Larsen, Monicaa,b,*; Storheim, Kjerstia,c; Stangeland, Helleb,d; Zwart, John-Ankera,b; Wentzel-Larsen, Tored,e; Skurtveit, Svetlanaf; Dyb, Greteb,d; Stensland, Synne Øiena,d. Childhood trauma and the use of opioids and other prescription analgesics in adolescence and young adulthood: The HUNT Study. PAIN 165(6):p 1317-1326, June 2024. | DOI: 10.1097/j.pain.0000000000003131 #trainpainacademy #cpdcourses #painmanagement #childhoodtrauma

"Comorbidities" | #MentalHealthWeek #PrimaryCare professionals, join Elizabeth Kerr, clinical neuropsychologist at The Hospital for Sick Children to discuss management of common psychiatric and somatic comorbidities associated with epilepsy. Patient case discussion follows. 📅 May 6 | 12-1pm REGISTER⤵ https://lnkd.in/gmfVQBtv #anxiety, #depression, #continuingmedicaleducation, #CME

💡 Fresh Featured Article: MDMA Therapy Goes Mainstream in Australia💡 Australia writes a new chapter in the history of mental health care with the world's first legal prescription of MDMA for chronic, treatment-resistant PTSD, thanks to Monarch Mental Health Group. This historic milestone signifies a monumental shift in psychiatric care, showcasing the potential of psychedelics to revolutionize treatment options for patients where traditional therapies have faltered. 🌏 A Global First: Dr. Ted Cassidy of Monarch Mental Health Group discusses the significance of issuing the world's first legal MDMA prescription. This pioneering step not only opens new avenues for treatment but also marks Australia as a leader in the integration of psychedelic-assisted therapy into healthcare. 🔍 Balancing Enthusiasm with Rigor: While this breakthrough brings hope, it underscores the importance of cautious and well-researched approaches to ensure patient safety and well-being. Psychedelics, with their long history of both traditional and recreational use, present an opportunity for innovative treatments when used responsibly within therapeutic settings. 🚀 Regulatory Milestones: Following the Therapeutic Goods Administration's (TGA) approval of MDMA and psilocybin for therapeutic use, Australia is at the forefront of embracing psychedelics for mental health. This decision reflects a broader shift towards acknowledging the therapeutic potential of psychedelics and paves the way for further research and acceptance. 🤝 A Bright Future for MDMA Therapy: As evidence of efficacy and safety continues to grow, there's hope for the integration of these treatments into national healthcare systems. Dr. Cassidy anticipates a swift move towards adopting MDMA therapy, potentially transforming mental health care and offering new hope to patients struggling with PTSD. The journey of MDMA-assisted therapy from groundbreaking prescription to potential widespread application underscores the evolving landscape of mental health treatment. Click the link below for more insights into this historic development and its implications for the future of psychiatry. Read the full article here: https://lnkd.in/gRfqCJ77 #mentalhealth #mdmatherapy #ptsd #psychedelics #innovationinhealthcare #psychiatriccare #australia #healthcarepolicy #mdma #mdmatherapy #ptsdtreatment #healthcarenews #news #medicalnews #psychedelicscience #psychedelicresearch #medicine